The Intelligent Asthma Monitoring Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of intelligent asthma monitoring devices has exhibited robust growth in the recent past. The market, which was valued at $1 billion in 2024, is expected to reach $1.08 billion in 2025, growing at a compound annual growth rate (CAGR) of 8.5%.
The Intelligent Asthma Monitoring Devices market is predicted to grow to a size of $1.48 billion by the year 2029. This growth is expected to follow a compound annual growth rate (CAGR) of 8.1%.
Download Your Free Sample of the 2025 Intelligent Asthma Monitoring Devices Market Report and Uncover Key Trends Now!The drivers in the intelligent asthma monitoring devices market are:
• Development of guidelines for asthma diagnosis
• Favorable regulatory environment
• Increased approvals for asthma monitoring devices
• Growing emphasis on preventive healthcare and adherence to smart inhalers.
The intelligent asthma monitoring devices market covered in this report is segmented –
1) By Product: Wearable Asthma Monitoring Devices, Smart Inhalers, Inhalers, Dry Powdered Inhalers, Metered Dose Inhalers, Nebulizers
2) By Technology: Manually Operated Inhalers, Digitally Operated Inhalers, Other Technologies
3) By End User: Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Other End Users
The trends in the intelligent asthma monitoring devices market are:
• Collaborations between pharmaceutical companies and smart inhaler manufacturers are becoming a key trend.
• The use of smartphone apps and mobile health solutions for asthma management is an emerging trend.
• The application of Ai-powered algorithms and machine learning for early prediction of asthma attacks is gaining traction.
• The integration of smart inhalers with digital health platforms is shaping the market's future.
The major players in the intelligent asthma monitoring devices market are:
• AstraZeneca plc
• 3M Company
• Boehringer Ingelheim International GmbH
• Teva Pharmaceuticals Industries Ltd
North America was the largest region in the intelligent asthma monitoring devices market in 2024